Giovanni Ambrosino

Summary

Affiliation: University of Padova
Country: Italy

Publications

  1. ncbi request reprint Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1
    Giovanni Ambrosino
    Department of Surgery and Gastroenterological Science, University of Padova, Padova, Italy
    Cell Transplant 14:151-7. 2005
  2. ncbi request reprint ALEX (artificial liver for extracorporeal xenoassistance): a new bioreactor containing a porcine autologous biomatrix as hepatocyte support. Preliminary results in an ex vivo experimental model
    G Ambrosino
    Department of Surgical and Gastroenterological Sciences, Section of General and Liver Transplant Surgery, University of Padova School of Medicine, Padova, Italy
    Int J Artif Organs 25:960-5. 2002
  3. ncbi request reprint Hepatocyte transplantation in the treatment of acute liver failure: microencapsulated hepatocytes versus hepatocytes attached to an autologous biomatrix
    Giovanni Ambrosino
    Department of Surgical and Gastroenterologic Sciences, Liver Transplant Unit, School of Medicine, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
    Cell Transplant 12:43-9. 2003
  4. ncbi request reprint Isolated hepatocytes versus hepatocyte spheroids: in vitro culture of rat hepatocytes
    Giovanni Ambrosino
    Department of Surgical and Gastroenterologic Sciences, Liver Transplant Unit, School of Medicine, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
    Cell Transplant 14:397-401. 2005
  5. ncbi request reprint Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support
    Giovanni Ambrosino
    Department of Surgical and Gastroenterological Sciences, University of Padova, Italy
    ASAIO J 48:592-7. 2002
  6. ncbi request reprint Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis
    Enrico Maria Zardi
    Interdisciplinary Center for Biomedical Research CIR, Laboratory of Internal Medicine and Hepatology and Campus Bio Medico University, School of Medicine, 00155 Roma, Italy
    In Vivo 20:377-80. 2006
  7. ncbi request reprint Cytokines and liver failure: modification of TNF- and IL-6 in patients with acute on chronic liver decompensation treated with Molecular Adsorbent Recycling System (MARS)
    Giovanni Ambrosino
    Department of Surgery and Gastroenterological Science, Liver Transplant Unit, University of Padova, Padova, Italy
    Acta Biomed 74:7-9. 2003
  8. ncbi request reprint Morphological and functional modifications of the aneurysm-endograft complex following endoluminal exclusion in 30 consecutive cases
    Mauro Frego
    Istituto di I Clinica Chirurgica Generale, Universita degli Studi di Padova
    Acta Biomed 74:45-50. 2003
  9. ncbi request reprint Image-guided robotic stereotactic radiosurgery for unresectable liver metastases: preliminary results
    Giovanni Ambrosino
    First School of General Surgery, University of Padua, 35128 Padova, Italy
    Anticancer Res 29:3381-4. 2009
  10. ncbi request reprint Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications
    Enrico Maria Zardi
    Interdisciplinary Center for Biomedical Research CIR, Laboratory of Internal Medicine and Hepatology, School of Medicine, Campus Bio Medico University, Via Emilio Longoni 83, 00155 Rome, Italy
    J Interferon Cytokine Res 24:297-300. 2004

Collaborators

Detail Information

Publications10

  1. ncbi request reprint Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1
    Giovanni Ambrosino
    Department of Surgery and Gastroenterological Science, University of Padova, Padova, Italy
    Cell Transplant 14:151-7. 2005
    ..Isolated AHT, though effective and safe, is not sufficient to correct CN1. Maintenance of adequate immunosuppression and family compliance are the main factors hampering the success of this procedure...
  2. ncbi request reprint ALEX (artificial liver for extracorporeal xenoassistance): a new bioreactor containing a porcine autologous biomatrix as hepatocyte support. Preliminary results in an ex vivo experimental model
    G Ambrosino
    Department of Surgical and Gastroenterological Sciences, Section of General and Liver Transplant Surgery, University of Padova School of Medicine, Padova, Italy
    Int J Artif Organs 25:960-5. 2002
    ..ALEX is a suitable cell support bioreactor, guaranteeing long-term maintenance of the metabolic activity of hepatocytes when compared to a standard BAL cartridge...
  3. ncbi request reprint Hepatocyte transplantation in the treatment of acute liver failure: microencapsulated hepatocytes versus hepatocytes attached to an autologous biomatrix
    Giovanni Ambrosino
    Department of Surgical and Gastroenterologic Sciences, Liver Transplant Unit, School of Medicine, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
    Cell Transplant 12:43-9. 2003
    ..PBMHcTx is a useful method to treat acute liver failure and it indicates a possible liver-direct gene therapy in the treatment of inherited and acquired disorders...
  4. ncbi request reprint Isolated hepatocytes versus hepatocyte spheroids: in vitro culture of rat hepatocytes
    Giovanni Ambrosino
    Department of Surgical and Gastroenterologic Sciences, Liver Transplant Unit, School of Medicine, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
    Cell Transplant 14:397-401. 2005
    ..We confirmed the role of extracellular matrix as a crucial component to promote hepatocyte homeostasis, and the close link between cellular architecture and tissue-specific functions...
  5. ncbi request reprint Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support
    Giovanni Ambrosino
    Department of Surgical and Gastroenterological Sciences, University of Padova, Italy
    ASAIO J 48:592-7. 2002
    ..Further studies are needed, but the results obtained with this new three-dimensional bioreactor are promising, and its potential is attractive...
  6. ncbi request reprint Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis
    Enrico Maria Zardi
    Interdisciplinary Center for Biomedical Research CIR, Laboratory of Internal Medicine and Hepatology and Campus Bio Medico University, School of Medicine, 00155 Roma, Italy
    In Vivo 20:377-80. 2006
    ....
  7. ncbi request reprint Cytokines and liver failure: modification of TNF- and IL-6 in patients with acute on chronic liver decompensation treated with Molecular Adsorbent Recycling System (MARS)
    Giovanni Ambrosino
    Department of Surgery and Gastroenterological Science, Liver Transplant Unit, University of Padova, Padova, Italy
    Acta Biomed 74:7-9. 2003
    ..The study confirms the efficacy of MARS therapy in terms of homeostasis of the cytokines network and suggests an usefulness of monitoring their level during liver failure...
  8. ncbi request reprint Morphological and functional modifications of the aneurysm-endograft complex following endoluminal exclusion in 30 consecutive cases
    Mauro Frego
    Istituto di I Clinica Chirurgica Generale, Universita degli Studi di Padova
    Acta Biomed 74:45-50. 2003
    ..Two pts needed anticoagulation. These data indicate that endoluminal aneurysm exclusion can not be considered as a definitive solution, for long-term outcome is unforeseeable in a number of patients...
  9. ncbi request reprint Image-guided robotic stereotactic radiosurgery for unresectable liver metastases: preliminary results
    Giovanni Ambrosino
    First School of General Surgery, University of Padua, 35128 Padova, Italy
    Anticancer Res 29:3381-4. 2009
    ....
  10. ncbi request reprint Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications
    Enrico Maria Zardi
    Interdisciplinary Center for Biomedical Research CIR, Laboratory of Internal Medicine and Hepatology, School of Medicine, Campus Bio Medico University, Via Emilio Longoni 83, 00155 Rome, Italy
    J Interferon Cytokine Res 24:297-300. 2004
    ..In light of these results, we suggest some possible therapeutic implications in patients with HCV infection. Further studies are necessary to confirm this hypothesis...